Literature DB >> 8536856

The role of central blood volume in the development of sodium retention in portal hypertensive rats.

L A Colombato1, A Albillos, R J Groszmann.   

Abstract

BACKGROUND & AIMS: In portal hypertension, peripheral vasodilatation (PVD) causes Na+ retention as a result of vascular underfilling. The central blood volume is responsible for the vascular filling signals to baroreceptors and volume receptors. The aim of this study was to determine the role of central blood volume in Na+ retention in portal hypertensive rats.
METHODS: Mean arterial pressure, portal pressure, cardiac output, total peripheral resistance, central blood volume, and extracellular Na+ space were assessed daily in rats after portal vein ligation or sham operation until a hyperdynamic circulatory state developed.
RESULTS: On day 1, portal vein-ligated rats had PVD and a diminished central blood volume (1.26 +/- 0.04 vs. 1.47 +/- 0.09 mL/100 g body wt; P < 0.05). On day 2, Na+ space increased in portal vein-ligated rats (38.1 +/- 0.5 vs. 33.1 +/- 0.5 mL/100 g body wt; P < 0.01). From day 2 on, normalization of central blood volume and cessation of Na+ retention were observed despite persistent PVD. On day 4, portal vein-ligated rats developed a hyperdynamic circulatory state with a normal central blood volume and persistent PVD.
CONCLUSIONS: Although total peripheral resistance remains decreased, Na+ retention ceases after central blood volume is normalized. Central blood volume therefore appears to be the signal for Na+ retention. Although PVD persists after Na+ retention ceases, it may contribute to Na+ retention by decreasing central blood volume.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8536856     DOI: 10.1053/gast.1996.v110.pm8536856

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  6 in total

Review 1.  Animal models of portal hypertension.

Authors:  Juan-G Abraldes; Marcos Pasarín; Juan-Carlos García-Pagán
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

2.  High arterial compliance in cirrhosis is related to low adrenaline and elevated circulating calcitonin gene related peptide but not to activated vasoconstrictor systems.

Authors:  J H Henriksen; S Møller; S Schifter; J Abrahamsen; U Becker
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

3.  Loss of tubuloglomerular feedback in decompensated liver cirrhosis: physiopathological implications.

Authors:  Giovanni Sansoè; Stefano Silvano; Giulio Mengozzi; Antonina Smedile; Giovanni Touscoz; Floriano Rosina; Mario Rizzetto
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

Review 4.  Cardiopulmonary complications in chronic liver disease.

Authors:  Soren Moller; Jens H Henriksen
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

5.  Arterial hypertension in cirrhosis: arterial compliance, volume distribution, and central haemodynamics.

Authors:  J H Henriksen; S Fuglsang; F Bendtsen; S Møller
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

6.  Effect of nitric oxide pathway regulation on water/sodium balance and renal function in a rodent model of acute liver and renal failure.

Authors:  Marek Saracyn; Tomasz Ząbkowski; Robert Zdanowski; Marek Brytan; Janusz Patera; Zbigniew Nowak; Grzegorz Kade; Zofia Wańkowicz
Journal:  Med Sci Monit       Date:  2014-09-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.